Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADAM23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM172A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADH1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRMD6-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NMNAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM53B-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100293211 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
DGAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAT16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTBK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLCO1C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on